Annual report pursuant to Section 13 and 15(d)

Net Loss Per Share (Schedule of Reconciliation of Net Loss to Net Loss Attributable to Heat Biologics, Inc.) (Details)

v3.19.1
Net Loss Per Share (Schedule of Reconciliation of Net Loss to Net Loss Attributable to Heat Biologics, Inc.) (Details) - USD ($)
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Earnings Per Share [Abstract]    
Net loss $ (16,591,293) $ (12,409,866)
Net loss: Non-controlling interest (857,439) (568,195)
Net loss attributable to Heat Biologics, Inc. $ (15,733,854) $ (11,841,671)
Weighted-average number of common shares used in net loss per share attributable to common stockholders - basic and diluted 17,485,461 3,845,342
Net loss per share applicable to Heat Biologics, Inc - basic and diluted $ (0.9) $ (3.08)